您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > IBMX
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
IBMX
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
IBMX图片
CAS NO:28822-58-4
包装与价格:
包装价格(元)
10mM (in 1mL DMSO)电议
50mg电议

产品介绍

化学性质

Physical AppearanceA solid
StorageStore at -20°C
M.Wt222.24
Cas No.28822-58-4
FormulaC10H14N4O2
Solubilityinsoluble in H2O; insoluble in EtOH; ≥9.45 mg/mL in DMSO
Chemical Name3-isobutyl-1-methyl-1H-purine-2,6(3H,7H)-dione
Canonical SMILESO=C(N(C)C1=O)N(C2=C1NC=N2)CC(C)C
运输条件蓝冰运输或根据您的需求运输。
一般建议为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同厂家不同批次产品溶解度各有差异,仅做参考。若实验所需浓度过大至产品溶解极限,请添加助溶剂助溶或自行调整浓度。溶液形式一般不宜长期储存,请尽快用完。

资料参考

IBMX is a widely-used non-specific inhibitor of phosphodiesterase (PDE) with IC50 values of 6.5±1.2, 26.3±3.9 and 31.7±5.3 μM for PDE3, 4 and 5 respectively[1].

By inhibiting PDEs, IBMX increases cellular cAMP and cGMP levels, activating cyclic-nucleotide-regulated protein kinases. Methylxanthines, including IBMX, caffeine, and theophylline, bind adenosine receptors, typically antagonizing the suppressive effects of natural agonists[2].

Sprague–Dawley rats receive an i.c.v. injection(IBMX or saline) 10 min before receiving an i.p. injectionof cocaine or saline. Intracerebroventricular IBMX does not affect the acute hyperlocomotor responseto cocaine, but when coadministered with cocaine for 7 consecutive days, attenuated development ofbehavioral sensitization. These results suggest that IBMX inhibition of PDE-mediated adenosine production[3].

References:

[1]. Wu BN, et al. KMUP-1, a xanthine derivative, induces relaxation of guinea-pig isolated trachea: the role of the epithelium, cyclic nucleotides and K+ channels. Br J Pharmacol, 2004, 142(7): 1105-14.

[2]. Snyder S H, Katims J J, Annau Z, et al. Adenosine receptors and behavioral actions of methylxanthines. Proc. Natl. Acad. Sci. USA, 1981, 78(5): 3260-3264.

[3]. Schroeder J A, Ruta J D, Gordon J S, et al. The phosphodiesterase inhibitor isobutylmethylxanthine attenuates behavioral sensitization to cocaine. Behavioural Pharmacology, 2012, 23(3): 310-314.